Liraglutide · 2026-08-12
ClinicalTrials.gov record NCT03883412
Recruiting at the retained observation.
Open attributed record →Official registry phase
Phase 4 peptide trials
23 selected ClinicalTrials.gov records carrying the official Phase 4 designation. Phase is reported exactly as supplied by the retained registry version; records without a supplied phase are not inferred into this page.
Registry records
23 selected records.
Connected peptides
9 profiles.
Source boundary
ClinicalTrials.gov phase field.
Attributed registry records
Selected records
Tirzepatide · 2026-07-28
ClinicalTrials.gov record NCT07191873
Not yet recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-07-22
ClinicalTrials.gov record NCT07257484
Recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-07-21
ClinicalTrials.gov record NCT07715929
Not yet recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-07-20
ClinicalTrials.gov record NCT07707778
Enrolling by invitation at the retained observation.
Open attributed record →Semaglutide · 2026-07-16
ClinicalTrials.gov record NCT06814938
Active, not recruiting at the retained observation.
Open attributed record →Elamipretide · 2026-07-13
ClinicalTrials.gov record NCT07531251
Recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-07-02
ClinicalTrials.gov record NCT05371496
Enrolling by invitation at the retained observation.
Open attributed record →Octreotide · 2025-05-09
ClinicalTrials.gov record NCT03289741
Completed at the retained observation.
Open attributed record →Lixisenatide · 2024-12-16
ClinicalTrials.gov record NCT02049034
Completed at the retained observation.
Open attributed record →Exenatide · 2023-12-29
ClinicalTrials.gov record NCT01524705
Completed at the retained observation.
Open attributed record →Semaglutide · 2023-09-08
ClinicalTrials.gov record NCT04263415
Completed at the retained observation.
Open attributed record →Teriparatide · 2023-08-02
ClinicalTrials.gov record NCT04026256
Completed at the retained observation.
Open attributed record →Leuprolide · 2018-01-23
ClinicalTrials.gov record NCT01116401
Completed at the retained observation.
Open attributed record →Liraglutide · 2015-03-25
ClinicalTrials.gov record NCT01755572
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-10-09
ClinicalTrials.gov record NCT01394341
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-07-30
ClinicalTrials.gov record NCT01911468
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-07-15
ClinicalTrials.gov record NCT01899430
Completed at the retained observation.
Open attributed record →Liraglutide · 2012-09-27
ClinicalTrials.gov record NCT01695109
Completed at the retained observation.
Open attributed record →Leuprolide · 2012-01-27
ClinicalTrials.gov record NCT00805935
Completed at the retained observation.
Open attributed record →Teriparatide · 2007-05-25
ClinicalTrials.gov record NCT00079924
Completed at the retained observation.
Open attributed record →Teriparatide · 2007-05-15
ClinicalTrials.gov record NCT00035256
Completed at the retained observation.
Open attributed record →Leuprolide · 2006-07-06
ClinicalTrials.gov record NCT00349258
Completed at the retained observation.
Open attributed record →